The R&D department carries out process development, formulation development and research for our domestic and international markets.
Shivalik Rasayan Limited believes that Research & Development (R&D) is the key for innovation and plays a decisive role in developing and adopting new technologies in the technologically rigorous pharmaceuticals industry.
Shivalik Rasayan Limited has ventured into the pharma domain with the state-of-the-art, facilities coming up in Dahej, Gujarat and Haridwar, Uttarkhand.
These facilities are fully dedicated Research & Development Center for development of oncology and non-oncology, and Active Pharmaceutical Ingredients (APIs), Finished Formulations, respectively.
SRL has focused on undertaking dedicated R&D in areas, which we believe, have significant growth potential. SRL believes that a systematic approach to selection of molecules, which involves evaluation of technical and commercial feasibility data, will result in commercialization of molecules as per globally accepted regulatory practices.
We believe that our R&D has led, and will continue to lead to new, innovative economically viable processes.
These will help increase the efficiency of production including developing cost effective manufacturing processes. In addition, it will help us address opportunities that we have identified in the global market for our businesses.
SRL is committed to continually generating the IP assets for in-house developed generic products, polymorph, process and novel technology by filing patents and trademarks across India and globally.
SRL’s R&D team consists of dedicated scientists in their respective areas. Our state-of-the-art R&D center is approved by the Department of Scientific and Industrial Research, Ministry of Science and Technology Government of India (“DSIR”) since April 2018.